Similarly, the anti-cancer small molecule ONC201/TIC10 has also been shown to inhibit colorectal CSC self-renewal via inhibiting Akt and ERK, and consequently activating FOXO3 to induce the expression of the death receptors TRAIL and DR5 (TRAIL-RII) [96]. Here, AKT1 is linked to cancer.